TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has provided an announcement.
Kintor Pharmaceutical Limited has announced changes to its Nomination Committee, effective June 26, 2025. Dr. Youzhi Tong has stepped down as chairman and member, with Ms. Geqi Wei joining as a member and Dr. Michael Min Xu taking over as chairman. These changes, along with revisions to the committee’s terms of reference, aim to enhance corporate governance and diversity, aligning with upcoming updates to the Corporate Governance Code.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing innovative therapies and has a market presence in Hong Kong, where it is publicly listed.
Average Trading Volume: 2,918,958
Technical Sentiment Signal: Buy
Current Market Cap: HK$691.3M
See more insights into 9939 stock on TipRanks’ Stock Analysis page.